Infections and immune factors in cancer: The role of epidemiology

Oncogene

Volumn 23, Issue 38, 2004, Pages 6341-6348

  Kinlen, Leo ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cancer; Immune impairment; Infections

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

BURKITT LYMPHOMA; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CHILDHOOD LEUKEMIA; DEVELOPING COUNTRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTION; NASOPHARYNX CANCER; NONHODGKIN LYMPHOMA; PERSISTENT INFECTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SKIN CANCER; STOMACH CANCER; TUMOR IMMUNITY; UTERINE CERVIX CANCER; IMMUNOLOGY; IMMUNOPATHOLOGY; NEOPLASM; RISK;

HUMAN IMMUNODEFICIENCY VIRUS;

HUMANS; IMMUNE SYSTEM DISEASES; INFECTION; NEOPLASMS; RISK;

EID: 4444248511     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207898     Document Type: Review

References (81)

1. Adami J, Gabel H, Lindelof, Ekstrom K, Rydh B, Glimelius B, Ekbom A, Adami H-O and Granath F. (2003). Br. J. Cancer, 89, 1221-1227.
2. Alexander FE, Boyle P, Carli PM, Coebergh JW, Ekbom A, Levi F, McKinney PA, McWhirter W, Michaelis J, Peris-Bonet R, Petridou E, Pompe-Kirn V, Plesko I, Pukkala E, Rahu M, Stiller CA, Storm H, Terracini B, Vatten L and Wray N. (1999). Eur. J. Cancer, 35, 439-444.
3. Alexander FE, Chan LC, Lam TH, Yuen P, Leung NK, Ha SY, Yuen HL, Li CK, Li CK, Lau YL and Greaves MF. (1997). Br. J. Cancer, 75, 457-763.
4. Beasley RP and Hwang L-Y. (1991). Viral Hepatitis and Liver Disease. Hollonger FB, Lemon SM and Margolis HS (eds). Williams and Wilkins: Baltimore, pp. 532-535.
5. Beasley RP, Hwang L-Y, Lin CC and Chien CS. (1981). Lancet, 2, 1129-1133.
6. Beral V, Peterman TA, Berkelman R and Jaffe H. (1990). Lancet, 335, 123-128.
7. Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohme I, Forsberg B, Eklund B, Fjeldborg O, Friedberg M, Frodin L, Glattre E, Halvorsen S, Holm NV, Jakobsen A, Jorgensen HE, Ladefoged J, Lindholm T, Lundgren G and Pukkala E. (1995). Int. J. Cancer, 60, 183-189.
8. Boschoff C and Weiss R. (2002). Nat. Rev.: Cancer, 2, 373-382.
9. Boutou O, Guizard AV, Slama R, Pottier D and Spira A. (2002). Br. J. Cancer, 87, 740-745.
10. Burkitt D. (1962). Nature, 194, 232-234.
11. Burnet FM. (1970). Prog. Exp. Tumor Res., 13, 1-27.
12. Castellsague X and Munoz N. (2003). J. Natl. Cancer Inst. Monogr., 31, 20-28.
13. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM and Moore PS. (1994). Science, 266, 1865-1869.
14. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW and Houghton M. (1989). Science, 244, 359-362.
15. Crawford DH, Edwards JMB, Sweny P, Hoffbrand AV and Janossy G. (1981). Int. J. Cancer, 28, 705-709.
16. Danesh J. (1999). Infections and Human Cancer: Cancer Surveys, 33. CSHL Press: New York.
17. Demeter LM, Stoler MH, Bonnez W, Corey L, Pappas P, Strussenberg J and Reichman RC. (1993). J. Infect. Dis., 168, 38-46.
18. Dickinson HO and Parker L. (1999). Br. J. Cancer, 81, 144-151.
19. Dockerty JD, Draper G, Vincent T, Rowan SD and Bunch KJ. (2001). Int. J. Epidemiol., 30, 1428-1437.
20. Doll R. (1999). Br. J. Cancer, 81, 3-5.
21. Donate F, Boffetta P and Puoti M. (1998). Int. J. Cancer, 75, 347-354.
22. Durst M, Gissmann L, Ikenberg H and zur Hausen H. (1983). Proc. Natl. Acad. Sci. USA, 80, 3812-3815.
23. Epstein MA, Achong BA and Barr YM. (1964). Lancet, 1, 702-703.
24. Franceschi S, Munoz N and Snijders PJ. (2000). Lancet, 356, 871-872.
25. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV and Sidransky D. (2000). J. Natl. Cancer Inst., 92, 709-720.
26. Greaves MF. (1988). Leukaemia, 7, 349-360.
27. Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL and Najarion JS. (1981). Cancer Res., 41, 4253-4261.
28. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, Rajkumar T, Svidhar H, Rose G, Pintos J, Fernandez L, Idris A, Sanchez MJ, Nieto A, Talamini R, Tavani A, Bosch FX, Reidel U, Snijders PJF, Meijer CJLM, Viscidi R, Munoz N and Franceschi S. (2003). J. Natl. Cancer Inst., 95, 1772-1783.
29. Herrington MM, Weiss NS and Olshan AF. (1996). Cancer epidemiology and Prevention. Scottenfeld D, Fraumeni JR (eds). Oxford University Press: New York, Oxford and Tokyo.
30. Hoover R and Fraumeni JF. (1973). Lancet, 2, 5-7.
31. Infante-Rivard C, Fortier I and Olsen E. (2000). Br. J. Cancer, 83, 1559-1564.
32. International Agency for Research on Cancer (IARC) (1994a). Monograph on the Evaluation of Carcinogenic Risks to Humans, Vol 59. IARC: Lyon.
33. International Agency for Research on Cancer (IARC) (1994b). Monograph on the Evaluation of Carcinogenic Risks to Humans, Vol 61. IARC: Lyon.
34. International Agency for Research on Cancer (IARC) (1995). IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans, Vol 64. IARC: Lyon.
35. Jourdan-Da Silva N, Perel Y, Mechinaud F, Plouvier E, Gandemer V, Lutz P, Vannier JP, Lamagnere JL, Margueritte G, Boutard P, Robert A, Armari C, Munzer M, Millot F, Lumley L de, Berthou C, Rialland Y, Pautard B, Hemon D and Clavel J. (2004). Br. J. Cancer, 90, 139-145.
36. Kinlen L. (1988). Lancet, 2, 1323-1327.
37. Kinlen L and Doll R. (2004). Br. J. Cancer, 91, (in press).
38. Kinlen LJ. (1995). Br. J. Cancer, 71, 1-5.
39. Kinlen LJ. (2000). Radiol. Prot. Bull., 226, 9-18.
40. Kinlen LJ and Balkwill A. (2001). Lancet, 357, 858.
41. Kinlen LJ and Balkwill A. In preparation.
42. Kinlen LJ, Clarke K and Hudson C. (1990). Lancet, 336, 577-582.
43. Kinlen LJ, Dickson M and Stiller CA. (1995). BMJ, 310, 763-768.
44. Kinlen LJ and Hudson C. (1991). BMJ, 303, 1357-1362.
45. Kinlen LJ and John SM. (1994). BMJ, 309, 1197-1202.
46. Kinlen LJ, O'Brien F, Clarke K, Balkwill A and Matthews F. (1993). BMJ, 306, 743-748.
47. Kinlen LJ and Petridou E. (1995). Cancer Causes Control, 6, 445-450.
48. Kinlen LJ and Pike MC. (1971). Lancet, 2, 398-402.
49. Kinlen LJ, Sheil AGR, Peto J and Doll R. (1979). BMJ, 2, 1461-1466.
50. Koushik A, King WD and McLaughlin JR. (2001). Cancer Causes Control, 12, 483-490.
51. Labrecque LG, Barnes DM, Fentiman IS and Griffin BE. (1995). Cancer Res., 55, 39-45.
52. Lin CT, Lin CR, Tan GK, Chen W, Dee AN and Chan WY. (1997). Am. J. Pathol., 150, 1745-1756.
53. Little J and Epidemiology of Childhood Cancer. (1999). Epidemiology of childhood cancer IARC Scientific Publications, Vol 149. International Agency for Research on Cancer: Lyon.
54. Ma X, Buffler PA, Selvin S, Mattay KK, Wiencke JK, Wiemels JL and Reynolds P. (2002). Br. J. Cancer, 86, 1419-1424.
55. MacMahon B. (1966). Cancer Res., 26, 1189-1200.
56. Magrath I and Bhatia K. (1999). J. Natl. Cancer Inst., 91, 1349-1350.
57. Newton R. (1996). Br. J. Cancer, 74, 1511-1513.
58. Newton R, Beral V and Weiss R. (1999a). Infections and Human Cancer. Cancer Surveys, Vol 33. CSHL Press: New York, pp. 237-262.
59. Newton R, Wu W and Anwar W. (1999b). Infections and Human Cancer. Cancer Surveys, Vol 33. CSHL Press: New York, pp. 291-311.
60. Old LJ, Boyse EA and Oettgen HF. (1966). Proc. Natl. Acad. Sci. USA, 56, 1699-1704.
61. Orth G, Jablonska S, Favre M, Croissant O, Jarzabek-Chorzelska M and Rzesa G. (1978). Proc. Natl. Acad. Sci. USA, 75, 1537-1541.
62. Parkin DM, Pisani P, Munoz N and Ferlay J. (1999). Infections and Human Cancer Cancer Surveys Vol 33. CSHL Press: New York.
63. Petridou E, Kassimos D, Kalmanti M, Kosmidis H, Haidas S, Flytzani V, Tong D and Trichopoulos D. (1993). BMJ, 307, 774.
64. Petridou E, Revinthi K, Alexander FE, Haidas S, Koliouskas D, Kosmidis H, Piperopoulou F, Tzortzatou F and Trichopoulos D. (1996). Br. J. Cancer, 73, 1278-1283.
65. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD and Gallo RC. (1980). Proc. Nat. Acad. Sci. USA, 77, 7415-7419.
66. Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, Wogan GN and Groopman JD. (1994). Cancer Epidemiol. Biomark. Prev., 3, 3-10.
67. Rigoni-Stern DA. (1842). G. serv. progr. patol. terapeut. Serie II, tomo II, 507-517.
68. Rosenbaum PF, Buck GM and Brecher ML. (2000). Am. J. Epidemiol, 152, 1136-1144.
69. Ross RK, Yuan J-M, Yu MC, Wogan GN, Qian GS, Tu JT, Groopman JD, Gao YT and Henderson BE. (1992). Lancet, 339, 943-946.
70. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ and Schreiber RD. (2001). Nature, 410, 1107-1111.
71. Smith EM, Huffman HT, Summersgill KS, Kirchner HL, Turek LP and Haugen TH. (1998). Laryngoscope. 108, 1098-1103.
72. Steenbergen RD, Hermsen MA, Walboomers JM, Joenje H, Arwert F and Meijer CJ. (1995). Cancer Res., 55, 5465-5471.
73. Thomas L. (1959). Cellular and Humoral Aspects of Hypersensitivity States. Lawrence HS (ed). Cassell: London, pp 529-532.
74. Uchiyama T, Yodoi J, Sagawa K, Takatsudi K and Uchino H. (1977). Blood, 50, 481-492.
75. Vizcaino AP, Parkin DM, Bofetta P and Skinner MEG. (1994). Cancer Causes Control, 5, 517-522.
76. Vonka V, Kanka J, Hirsh I, Zavadova H, Krcmar M, Suchankova A, Rezacova D, Broucek J, Press M, Domorazkova E, Svoboda B, Havrankova A and Jelinek J. (1984). Int. J. Cancer, 33, 61-66.
77. Warren JR and Marshall BJ. (1983). Lancet, 1, 1273.
78. Wild CP, Rasheed FN, Jawla MF, Hall AJ, Jansen LA and Montesano R. (1991). Lancet, 337, 1602.
79. Xue SA, Lampert IA, Haldane JS, Bridger JE and Griffin BE. (2003). Br. J. Cancer, 89, 113-119.
80. Yasui Y, Potter JD, Stanford JL, Rossing MA, Winget MD, Bronner M and Daling J. (2001). Cancer Epidemiol. Biomark. Prev., 10, 9-16.
81. Yu MW and Chen CJ. (1993). Cancer Res., 53, 790-794.